GlobalData on MSN4d
Eton secures US patent for diabetes insipidus treatment
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...
JD Supra4d
Renewed Efforts in Congress for Pharmaceutical Patent Reform
With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent ...
Kiora Pharmaceuticals secures new patent for KIO-104
ENCINITAS, CA - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a small-cap biotech firm with a market capitalization of $10.47 million and strong financial health according to InvestingPro analysis, has ...
Bristol-Myers Squibb: Solid Q4 Earnings, But Weak Guidance And Patent Concerns Drive The Stock Down
Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...
Medscape11d
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
Finanznachrichten7d
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
The patent expires in 2044 and is ... risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in ...
PharmiWeb4d
Pharmaceutical Market: Shaping the Future of Healthcare and Medicine
Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...